DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Posição atual:
>
>
> This Story

Forward Printable StoryPrint Comment

 

 

Alzheimers/Neurology Homepage

Israel includes Neuravive focused ultrasound for essential tremor in health services plan

Study shows higher risk of dementia for adults with congenital heart disease

FDA grants marketing authorization to Banyan biomarkers for the first diagnostic blood test for TBI

Cerveau Technologies signs research agreement with MGH

'The Virtual Brain' allows researchers to study brain function

Scientists have developed a new technique to map electrical circuits in the brain far more comprehensively than ever before

FDA clears Combinostics’ MR quantification software cNeuro cMRI

Largest clinical study of Parkinson's disease reaches 10,000-patient milestone, reveals critical learnings

Chemistry scholars develop world-first array of multifunctional compounds for detection, imaging and treatment of Alzheimer's

Spectratech announces its portfolio of functional near-infrared spectroscopy devices

Undergraduates develop tools to diagnose Alzheimer's disease before patients show symptoms

Press releases may be edited for formatting or style
COLLEGE PARK, Md. - A team of seven University of Maryland A. James Clark School of Engineering undergraduates earned the top prize in this year's National Institutes of Health (NIH) Design by Biomedical Undergraduate Teams (DEBUT) challenge for their efforts to develop low-cost tools to diagnose Alzheimer's disease before patients show symptoms.

"This represents a monumental achievement, not simply for the engineering community, but for the wider world of human health research," said Darryll J. Pines, dean of the Clark School and Nariman Farvardin Professor. "As rising sophomores, these seven students in many ways represent the future of biomedical innovation. Through collaborations with faculty and researchers across a range of disciplines, they have transformed ideas into innovation that could one day change how Alzheimer's and other diseases are diagnosed."

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras



The team, known as "Synapto," was awarded $20,000 from the NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB) for developing a portable electroencephalogram (EEG) that uses a specially designed headset and a new software analysis tool to detect Alzheimer's disease before a patient displays clinical symptoms. The device exploits changes observed in the brainwaves of Alzheimer's patients in response to special auditory tones. The team, which recently filed for a company LLC in Maryland, believes their work could help make dementia diagnosis more quantitative, more systematic, and less costly - allowing doctors to use it at regular check-ups.

"Alzheimer's disease is the sixth leading cause of death in the United States, costing the nation close to $259 billion this year," said UMD Fischell Department of Bioengineering (BIOE) undergraduate and Synapto team captain Dhruv Patel, citing data from the Alzheimer's Association. "Diagnosing the disease early on allows patients to open up treatment options, manage the disease properly, and slow its progression."

Today, PET scans, MRIs, and spinal taps are most commonly used to diagnose Alzheimer's disease. Such methods are expensive and, at times, invasive, so many patients are diagnosed based only on their symptoms.

"It can take up to two years after clinical symptoms arise for patients to receive a proper diagnosis, and by then, he or she may have already seen significant progression of the disease," Patel said. "To address this, our technique allows us to characterize an Alzheimer's patient's brainwave using a variety of mathematical analytical tools and compare it with a healthy patient's brainwave to create a machine-learning model that can then accurately predict the probability of the patient having the disease."
  Pages: 1 - 2 >>

Alzheimers/Neurology Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente a Sua Perceção da Marca
Leilões + Vendas Privadas
Comece
O mais melhor preço
Comprar Equipamento/Peças
Encontre
O preço o mais baixo
Notícia diária
Leia
A notícia a mais atrasada
Diretório
Browse tudo
DOTmed Usuários
Ética no DOTmed
Veja o nosso
Programa das éticas
O ouro parte o programa do vendedor
Receba PH
Pedidos
Programa do negociante do serviço do ouro
Receba RFP/PS
Pedidos
Fornecedores de Healthcare
Veja tudo
Ferramentas de HCP
Trabalhos/Treinamento
Achado/suficiência
Um trabalho
Parts Hunter +EasyPay
Comece as peças
Citações
Certificado recentemente
Vista recentemente
Usuários certificados
Recentemente Rated
Vista recentemente
Usuários certificados
Central Rental
Equipamento do aluguel
Para menos
Vender Equipamentos/Peças
Comece
A maioria de dinheiro
Preste serviços de manutenção ao Forum dos técnicos
Ajuda do achado
E conselho
Simples RFP
Comece o equipamento
Citações
Mostra de comércio virtual
Serviço do achado
Para o equipamento
O acesso e o uso deste local são sujeitos aos termos e às condições do nosso OBSERVAÇÃO LEGAL & OBSERVAÇÃO DA PRIVACIDADE
Propriedade de e proprietário DOTmeda .com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
TODOS OS DIREITOS RESERVADOS